Physical, chemical and kinetic factors affecting prion infectivity

REFERENCES

• Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363-83; http://dx.doi.org/10.1073/pnas.95.23.13363
   PubMed Web of Science ®Google Scholar
• Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001; 24:519-50; PMID:11283320; http://dx.doi.org/10.1146/annurev.neuro.24.1.519
   PubMed Web of Science ®Google Scholar
• Collinge J. Molecular neurology of prion disease. J Neurol Neurosurg Psychiatry 2005; 76:906-19; PMID:15965195; http://dx.doi.org/10.1136/jnnp.2004.048660
   PubMed Web of Science ®Google Scholar
• Collinge J, Clarke A. A general model of prion strains and their pathogenicity. Science 2007; 318:930-6; PMID:17991853; http://dx.doi.org/10.1126/science.1138718
   PubMed Web of Science ®Google Scholar
• Griffith JS. Self Replication and scrapie. Nature 1967; 215:1043-4; PMID:4964084; http://dx.doi.org/10.1038/2151043a0
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136-44; PMID:6801762; http://dx.doi.org/10.1126/science.6801762
   PubMed Web of Science ®Google Scholar
• Riesner D. Biochemistry and structure of PrP(C) and PrP(Sc). Br Med Bull 2003; 66:21-33; PMID:14522846; http://dx.doi.org/10.1093/bmb/66.1.21
   PubMed Web of Science ®Google Scholar
• Weissmann C. The state of the prion. Nat Rev Microbiol 2004; 2:861-71; PMID:15494743; http://dx.doi.org/10.1038/nrmicro1025
   PubMed Web of Science ®Google Scholar
• Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, Caughey B. The most infectious prion protein particles. Nature 2005; 437:257-61; PMID:16148934; http://dx.doi.org/10.1038/nature03989
   PubMed Web of Science ®Google Scholar
• Caughey B, Baron GS. Prions and their partners in crime. Nature 2006; 443:803-10; PMID:17051207; http://dx.doi.org/10.1038/nature05294
   PubMed Web of Science ®Google Scholar
• Sandberg MK, Al Doujaily H, Sharps B, Clarke AR, Collinge J. Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 2011; 470:540-2; PMID:21350487; http://dx.doi.org/10.1038/nature09768
   PubMed Web of Science ®Google Scholar
• Li J, Browning S, Mahal SP, Oelschlegel AM, Weissmann C. Darwinian evolution of prions in cell culture. Science 2010; 327:869-72; PMID:20044542; http://dx.doi.org/10.1126/science.1183218
   PubMed Web of Science ®Google Scholar
• Collinge J. Medicine. Prion strain mutation and selection. Science 2010; 328:1111-2; PMID:20508117; http://dx.doi.org/10.1126/science.1190815
   PubMed Web of Science ®Google Scholar
• Chandler RL. Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet 1961; 1(7191):1378-9; PMID:13692303; http://dx.doi.org/10.1016/S0140-6736(61)92008-6
   PubMed Web of Science ®Google Scholar
• Klohn P, Stoltze L, Flechsig E, Enari M, Weissmann C. A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proc Natl Acad Sci USA 2003; 100:11666-71; PMID:14504404; http://dx.doi.org/10.1073/pnas.1834432100
   PubMed Web of Science ®Google Scholar
• Sandberg MK, Al Doujaily H, Sharps B, De Oliveira MW, Schmidt C, Richard-Londt A, Lyall S, Linehan JM, Brandner S, Wadsworth JD, et al. Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked. Nat Commun 2014; 5:4347; PMID:25005024; http://dx.doi.org/10.1038/ncomms5347
   PubMed Web of Science ®Google Scholar
• Cronier S, Gros N, Tattum MH, Jackson GS, Clarke AR, Collinge J, Wadsworth JD. Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem J 2008; 416:297-305; PMID:18684106; http://dx.doi.org/10.1042/BJ20081235
   PubMed Web of Science ®Google Scholar
• Bolton DC, Bendheim PE. Purification of scrapie agents: How far have we come. Curr Top Microbiol Immunol 1991; 172:39-55; PMID:1687384
   PubMedGoogle Scholar
• Deleault NR, Harris BT, Rees JR, Supattapone S. Formation of native prions from minimal components in vitro. Proc Natl Acad Sci USA 2007; 104:9741-6; PMID:17535913; http://dx.doi.org/10.1073/pnas.0702662104
   PubMed Web of Science ®Google Scholar
• Wang F, Wang X, Yuan CG, Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 2010; 327:1132-5; PMID:20110469; http://dx.doi.org/10.1126/science.1183748
   PubMed Web of Science ®Google Scholar
• Deleault NR, Piro JR, Walsh DJ, Wang F, Ma J, Geoghegan JC, Supattapone S. Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc Natl Acad Sci U S A 2012; 109(22):8546-51
   PubMed Web of Science ®Google Scholar
• Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C. Mice devoid of PrP are resistant to scrapie. Cell 1993; 73:1339-47; PMID:8100741; http://dx.doi.org/10.1016/0092-8674(93)90360-3
   PubMed Web of Science ®Google Scholar
• Herrmann LM, Caughey B. The importance of the disulfide bond in prion protein conversion. Neuro Report 1998; 9:2457-61; PMID:9721914; http://dx.doi.org/10.1097/00001756-199808030-00006
   PubMed Web of Science ®Google Scholar
• Welker E, Wedemeyer WJ, Scheraga HA. A role for intermolecular disulfide bonds in prion diseases? Proc Natl Acad Sci USA 2001; 98:4334-6; PMID:11274354; http://dx.doi.org/10.1073/pnas.071066598
   PubMed Web of Science ®Google Scholar
• Welker E, Raymond LD, Scheraga HA, Caughey B. Intramolecular vs. intermolecular disulfide bonds in prion proteins. J Biol Chem 2002; 277(36):33477-81
   PubMed Web of Science ®Google Scholar
• Lucassen R, Nishina K, Supattapone S. In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups. Biochem 2003; 42:4127-35; PMID:12680767; http://dx.doi.org/10.1021/bi027218d
   PubMed Web of Science ®Google Scholar
• Maiti NR, Surewicz WK. The role of disulfide bridge in the folding and stability of the recombinant human prion protein. J Biol Chem 2001; 276:2427-31; PMID:11069909; http://dx.doi.org/10.1074/jbc.M007862200
   PubMed Web of Science ®Google Scholar
• Hosszu LL, Wells MA, Jackson GS, Jones S, Batchelor M, Clarke AR, Craven CJ, Waltho JP, Collinge J. Definable Equilibrium States in the Folding of Human Prion Protein. Biochem 2005; 44:16649-57; http://dx.doi.org/10.1021/bi051277k
   PubMed Web of Science ®Google Scholar
• Zelphati O, Szoka FC, Jr. Mechanism of oligonucleotide release from cationic liposomes. Proc Natl Acad Sci U S A 1996; 93:11493-8; PMID:8876163; http://dx.doi.org/10.1073/pnas.93.21.11493
   PubMed Web of Science ®Google Scholar